|
| 36711764 | Physical Activity Delays Obesity-Associated Pancreatic Ductal Adenocarcinoma in Mice and Decreases Inflammation. | bioRxiv | 2023 |
| 35723106 | Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching. | J Alzheimers Dis | 2022 |
| 34341059 | Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma. | Clin Cancer Res | 2021 |
| 33792569 | ATP11B mediates platinum resistance in ovarian cancer. | J Clin Invest | 2021 |
| 34648891 | Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications. | J Control Release | 2021 |
| 32490257 | An immune competent orthotopic model of endometrial cancer with metastasis. | Heliyon | 2020 |
| 31906456 | Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression. | Cancers (Basel) | 2020 |
| 32669559 | ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment. | Nat Commun | 2020 |
| 32109374 | Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer. | Cancer Cell | 2020 |
| 31092618 | Correction: Focal Adhesion Kinase Targeting Using <i>In vivo</i> Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy. | Clin Cancer Res | 2019 |
| 29716897 | Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer. | Cancer Prev Res (Phila) | 2018 |
| 29809169 | ATP11B mediates platinum resistance in ovarian cancer. | J Clin Invest | 2018 |
| 27931017 | Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN. | Oncology | 2017 |
| 28498246 | Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition. | Int J Gynecol Cancer | 2017 |
| 27021436 | Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. | Nat Commun | 2016 |
| 27903150 | Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. | J Clin Oncol | 2016 |
| 27745917 | Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study. | Gynecol Oncol | 2016 |
| 24651628 | The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. | Int J Gynecol Cancer | 2014 |
| 25042259 | Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. | Cancer | 2014 |
| 24680596 | CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity. | Gynecol Oncol | 2014 |
| 23344261 | Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. | Clin Cancer Res | 2013 |
| 24077915 | Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. | Mol Cancer Ther | 2013 |
| 23500454 | Chemopreventive effects of metformin on obesity-associated endometrial proliferation. | Am J Obstet Gynecol | 2013 |
| 23585472 | ATP11B mediates platinum resistance in ovarian cancer. | J Clin Invest | 2013 |
| 22167410 | Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. | Clin Cancer Res | 2012 |
| 21802066 | Understanding obesity and endometrial cancer risk: opportunities for prevention. | Am J Obstet Gynecol | 2011 |
| 20009575 | Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. | Cancer Biol Ther | 2010 |
| 20708159 | Regulation of tumor angiogenesis by EZH2. | Cancer Cell | 2010 |
| 19470734 | Therapeutic Targeting of ATP7B in Ovarian Carcinoma. | Clin Cancer Res | 2009 |
| 19641174 | EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. | J Natl Cancer Inst | 2009 |
| 19383821 | Estrous cycle modulates ovarian carcinoma growth. | Clin Cancer Res | 2009 |
| 19092150 | Dicer, Drosha, and outcomes in patients with ovarian cancer. | N Engl J Med | 2008 |
| 19383336 | Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis. | Mol Oncol | 2008 |
| 17072347 | Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions. | Oncogene | 2007 |
| 17885490 | Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis. | Int J Gynecol Pathol | 2007 |
| 17308118 | Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. | Cancer Res | 2007 |
| 17332928 | Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites. | Int J Oncol | 2007 |
| 16380413 | Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. | J Clin Oncol | 2006 |
| 17106249 | Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer. | Cancer Biol Ther | 2006 |
| 17077358 | Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. | J Natl Cancer Inst | 2006 |
| 16969087 | Analysis of EphA2 expression and mutant p53 in ovarian carcinoma. | Cancer Biol Ther | 2006 |
| 16855388 | The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. | Cancer Biol Ther | 2006 |
| 16914580 | Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. | Clin Cancer Res | 2006 |
| 16061675 | Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. | Cancer Res | 2005 |
| 16361572 | Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. | Clin Cancer Res | 2005 |
| 15159305 | Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. | Cancer Epidemiol Biomarkers Prev | 2004 |
| 15385107 | Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. | Gynecol Oncol | 2004 |
| 15161682 | Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. | Clin Cancer Res | 2004 |
| 12821340 | Overexpression of kallikrein 10 in epithelial ovarian carcinomas. | Gynecol Oncol | 2003 |
| 12910520 | Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. | Cancer | 2003 |